The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,3-Bis-(1-methyl-1H-indol-3-yl)-propenone ID: ALA1834570
PubChem CID: 56678496
Max Phase: Preclinical
Molecular Formula: C21H18N2O
Molecular Weight: 314.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(/C=C/C(=O)c2cn(C)c3ccccc23)c2ccccc21
Standard InChI: InChI=1S/C21H18N2O/c1-22-13-15(16-7-3-5-9-19(16)22)11-12-21(24)18-14-23(2)20-10-6-4-8-17(18)20/h3-14H,1-2H3/b12-11+
Standard InChI Key: YAKSLYJQYXCGCH-VAWYXSNFSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
0.9957 0.9970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2797 0.5873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4332 1.0024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1171 -0.3098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3017 -0.1838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1697 0.6305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9033 1.0078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1139 1.8054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9100 2.0219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4955 1.4408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2849 0.6431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4889 0.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4943 -1.0436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0133 0.2996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4636 0.9147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7087 0.5819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7918 -0.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2376 -0.8499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4896 -1.6355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2959 -1.8100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8502 -1.1989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5982 -0.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8341 0.3827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4302 1.8274 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
4 12 1 0
7 12 2 0
4 13 1 0
3 6 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
14 22 1 0
17 22 2 0
14 23 1 0
1 16 1 0
3 24 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 314.39Molecular Weight (Monoisotopic): 314.1419AlogP: 4.57#Rotatable Bonds: 3Polar Surface Area: 26.93Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.54CX LogD: 4.54Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.40Np Likeness Score: -0.45
References 1. Martel-Frachet V, Kadri M, Boumendjel A, Ronot X.. (2011) Structural requirement of arylindolylpropenones as anti-bladder carcinoma cells agents., 19 (20): [PMID:21908193 ] [10.1016/j.bmc.2011.08.015 ] 2. Valdameri G, Gauthier C, Terreux R, Kachadourian R, Day BJ, Winnischofer SM, Rocha ME, Frachet V, Ronot X, Di Pietro A, Boumendjel A.. (2012) Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity., 55 (7): [PMID:22449016 ] [10.1021/jm2016528 ]